EXCLUSIVE: Ocean Biomedical’s Co-Founder Expects To Receive US Patent Covering Malaria Therapeutics
Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jonathan Kurtis, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S.